Latest

Why is vaxxed and boosted Covid-positive Kamala Harris taking Pfizer’s Paxlovid?

April 27, 2022 | | Print Article

The vice president has a problem—she’s tested positive for COVID-19.

And this amidst her other pressing cares, including handling the obscene border crisis and trying to defuse the first major European war since World War II.

Yesterday, VP Kamala Harris tweeted: “Today I tested positive for COVID-19. I have no symptoms, and I will continue to isolate and follow CDC guidelines.” It was a pretty standard statement, and was followed, of course, by the obligatory “I’m grateful to be both vaccinated and boosted.”

Naturally, that prompted the usual Twitter wits to chime in:

The vice president has, in fact, received the full regimen of preventative treatments for COVID, which includes both vaccinations (two shots) and two booster shots to supercharge her immunity. In other words, she ought to be quadruply insulated against the disease. And now comes the surprising word from the vice president’s office that she’ll be undergoing a further treatment: Pfizer’s newly-released antiviral pill Paxlovid.

And that’s a curious development, considering that she’s not displaying any symptoms and is fully vaccinated and boosted.

Needless to say, many people are not happy that the vice president, who is 57 and seems to be in excellent health, has access to medications that are better reserved for those who truly need them.

Even medical professionals are questioning the need for Harris to be prescribed such powerful antivirals.

Dr. Walid Gellad, professor of medicine at the University of Pittsburgh, had this to say: “The VP is quadruple vaccinated with no symptoms and is taking paxlovid. Not the clinical trial population.”

“I understand who this person is,” he continued, “but isn’t this prescribing even outside of the EUA, which is for people with Covid (e.g., symptoms)?”

The EUA (Emergency Use Authorization) from the Food and Drug Administration has strict guidelines for the use of the drug, which doesn’t seem to fit the vice president’s situation: “The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the unapproved product PAXLOVID for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients…who are at high risk for progression to severe COVID-19, including hospitalization or death.”

Moreover, the drug is not authorized for asymptomatic patients, as is apparently the case with Harris. And that’s to say nothing of the host of potentially nasty side effects.

But maybe we’re reading too much into the whole thing. Sometimes, in these cases, it really is all about the “optics.”

The White House, of late, has been pushing Paxlovid as a “miracle pill,” a panacea that will finally slay the COVID dragon.

So maybe it’s really just about politics, after all.

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

$10
$15
$25
$50
Other
$
Success! Thank you for donating. Please share BPR content to help combat the lies.
Todd Jaquith
Latest posts by Todd Jaquith (see all)

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

PLEASE JOIN OUR NEW COMMENT SYSTEM! We love hearing from our readers and invite you to join us for feedback and great conversation. If you've commented with us before, we'll need you to re-input your email address for this. The public will not see it and we do not share it.

Latest Articles